VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V.
Position in MEDP — Medpace Holdings, Inc.
CIK 1367401
AMSTERDAM, P7
Position in MEDP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,317,076
New position
Shares Held
17,593
first reported quarter
Ownership
0.063%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#127
of 689 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 70%
Shared 0%
None 30%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. holds $508,932,840 across 8 Diagnostics & Research names. MEDP ranks #6 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
444,819 | $223,014,453 | |
| 2 | ICLR |
Icon PLC
|
961,665 | $167,050,827 | |
| 3 | DGX |
Quest Diagnostics Inc
|
242,907 | $51,484,138 | |
| 4 | SHC |
Sotera Health Co
|
1,403,962 | $24,920,325 | |
| 5 | QGEN |
Qiagen N.V.
|
398,095 | $15,565,514 | |
| 6 | MEDP |
Medpace Holdings, Inc.
This page
|
17,593 | $9,317,076 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
46,773 | $9,037,479 | |
| 8 | DHR |
Danaher Corp /De/
|
44,850 | $8,543,028 |
All Filings in MEDP
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,317,076 | 17,593 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||